Urokinase for Injection 50,000IU Technical Specification:
| Product Name: | Urokinase for Injection |
| Brand Name: | UVANTAJ |
| Strength: | 5,00,000IU, 5000IU, 50,000IU, 1,00,000UI, 2,50,000IU |
| Dosage Form: | Lyophilized Powder Injection (Sterile) *Pyrogen Free |
| Packing: | 1 Vial |
| Route of Administration: | For I.V. use only |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-coagulant (thrombolytic) |
| Indication: | UROKINASE breaks up blood clots. It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes. Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells. Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine. |
| Storage: | Store at 2°C to 8°C. Protect from light |
Urokinase 50,000IU Injection Manufacturers, Suppliers in India:
Taj Pharmaceuticals is of the prominent Urokinase 50,000IU Injection Manufacturers in India, bringing the best quality products. Our company Taj Pharma has rich experience in the niche manufacturing of Urokinase Injection.
Taj Pharmaceuticals is a reputed manufacturer and Urokinase 50,000IU Injection Supplier in India prefer Taj Pharma is best known for the topmost standards and consistent quality of its products.
Urokinase 50,000IU Injection in the treatment of post-operation blood clots. Urokinase is used to treat large blood clots formed in the lungs. Urokinase Injection is a physiologic thrombolytic agent that is produced in renal parenchymal cells. Unlike alternatives like streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine.
Taj Pharma is a well-known Urokinase 50,000IU Injection Manufacturer in India that assures high- quality and high standards. Strict quality control ensures that every batch of medicine brings a harmonious standard.
Urokinase 50,000IU Injection manufactured at Taj Pharma follow ICH; i.e., the product is manufactured to comply with good quality standards, considered the Best in the world. Further, Taj Pharma uses Urokinase 50,000IU Injection grade best active ingredient to manufacture its Injections to comply with international standards of European products.
Urokinase Injection PAN India Manufacturers, Suppliers
Taj Pharmaceuticals Limited is one of India’s most reputable and widely recognized manufacturers of high-quality anticoagulant Urokinase Injection. We excel at maintaining the highest industry standards as we work to become one of the top suppliers and exporters in the pharmaceutical sector for Urokinase Lyophilized Injection. We have a cutting-edge manufacturing facility that is furnished with all the necessary tools, equipment, and resources required for the production of Urokinase 50,000IU Injection.
What is Urokinase Injection?
Urokinase is a kind of anticoagulant injection used to break down harmful blood clots formed in the blood vessels of patients. Urokinase is used in the treatment of patients suffering from a recent cardiac heart attack. Urokinase, a blood clot removing agent is also used in the treatment of pulmonary embolism and strokes.
Why Taj Pharmaceuticals Limited?
Taj Pharmaceuticals Limited is one of India’s leading Urokinase Injection manufacturers, and it is the top anticoagulant in the post operation harmful blood clots formation treatment. Urokinase 50,000IU Injection lowers the blood pressure and makes it easier for patients’ heart to pump blood around body. Reducing the probability of a heart attack due to blocked blood vessels due to clots. Urokinase Injection may also reduce the risk of death if it is given immediately after a cardiac arrest. Urokinase is always given as an injection by a doctor in critical situations or nurse and should not be self-administered.
We are exporting our Urokinase Injection product in Following Countries:
GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq.
North and Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Suriname,
South America: Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Uruguay, Venezuela
Caribbean Countries: Jamaica, Cuba, Dominican Republic, Haiti, Guadeloupe, Martinique, Puerto Rico, Saint-Barthélemy, Saint-Martin, St Lucia, Trinidad & Tobago,
Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine,
African Countries: Kenya, Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia, Mozambique, Malawi, Seychelles, Gambia, Somalia, Sierra Leone, Libya
Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam
Other Countries: Turkey, Cyprus, Cayman Island, Papua New Guinea (PNG), All West Indies Country
Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius
Urokinase Injection Regulatory Documents:
- Certificate of Analysis (COA)
- Method of Analysis (MOA)
- Stability Data (Accelerated stability / Long term stability / Zone 4b)
- CTD Dossier / ACTD Dossiers / eCTD Dossiers
- Certificate of Pharmaceuticals Product (COPP)